| Registry | NCT03408041 |
|---|---|
| Status | Completed |
| Study type | Observational |
| Enrollment | 129 (Actual) |
| Sponsor | Murielle Surquin (Other) |
| Conditions | Alzheimer Disease |
| Interventions | Medical file data extraction (Other) |
| Dates | start 2016-05-01, primary completion 2017-10-01, completion 2017-10-01, first posted 2018-01-23, last updated 2018-01-23 |
| Locations | 1 site in Belgium |
Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Alzheimer Disease All trials of Medical file data extraction
The early diagnosis of Alzheimer's disease is essential to enable patients to have access to the available treatments. However, there is a delay between the diagnosis and the onset of symptoms, which can range from 1 year to more than 5 years. In clinical practice, the hippocampal volume, measured by the Scheltens index, is currently used as a marker of the progression of the disease.
The purpose of this study is to determine whether the patient's sex, age and ethnicity can influence the delay in the expression of cognitive troubles reported by the family at the first medical consultation, as well as to determine if there is a correlation between the delay reported by the family and the Scheltens index.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Alzheimer Disease | Other: Medical file data extraction | Alzheimer Disease patients admitted in the 'Memory Clinic' of the CHU Brugmann Hospital between 01-01-2010 and 31-01-2013. Diagnose according to the Dubois criteria |
Sex: All
Inclusion Criteria: Alzheimer Disease patients admitted in the 'Memory Clinic' of the CHU Brugmann Hospital between 01-01-2010 and 31-01-2013. Diagnose according to the Dubois criteria Exclusion Criteria: None
| Facility | City | Country | Status |
|---|---|---|---|
| CHU Brugmann | Brussels | Belgium |